ArticleThe Journal of organic chemistry2026
Internally Directed Stereochemical Alteration of Alkene Dihalogenation.
Article in The Journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Electrophilic dihalogenation of alkenes is a powerful strategy for the construction of configurationally defined vicinal dihalides. However, because of its inherent anti-stereospecificity, the practical synthetic access has been largely restricted to only half of the diastereochemical space. Although recent advances enabled complementary syn-dihalogenations through sequences involving anti-addition followed by stereoinversion, these approaches often suffer from limitations when applied to aryl-substituted alkenes that are prone to loss of stereochemical integrity during electrophilic activation via stable benzylic cation formation. Our group previously reported an efficient syn-dichlorination of N-protected allylic amines by exploiting an internal assistance mechanism of a systematically identified stereodirecting group, which notably accommodated aryl alkenes. We present here a full account describing the detailed course of our study, including further efforts to expand the substrate and halogen scopes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.